Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 4/20 | 0.46 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.42 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
| ▸ | ACHE | P22303 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL5673726 | 0.98 | HRH3 (0.44) | HRH3SIGMAR1ALDH1A1HTTMCHR1 | |
| SCHEMBL7333053 | 0.98 | SIGMAR1 (0.45) | HRH3SIGMAR1ALDH1A1HTTMCHR1 | |
| Hydrochloric Acid SCHEMBL7338771 | 0.97 | SIGMAR1 (0.44) | HRH3SIGMAR1ALDH1A1HTTMCHR1 | |
| Hydrochloric Acid SCHEMBL7339147 | 0.85 | KMT2A (0.49) | HRH3SIGMAR1ALDH1A1SMN1; SMN2KDM4E | |
| SCHEMBL7337477 | 0.84 | SLC6A2 (0.44) | HRH3SIGMAR1 | |
| SCHEMBL10693219 | 0.83 | HRH3 (0.46) | HRH3ALDH1A1HTTSMN1; SMN2HRH4 | |
| Hydrochloric Acid SCHEMBL7336348 | 0.83 | HRH3 (0.46) | HRH3SIGMAR1ALDH1A1SMN1; SMN2HRH4 | |
| Hydrochloric Acid SCHEMBL7337646 | 0.83 | SLC6A2 (0.43) | HRH3SIGMAR1 | |
| Hydrochloric Acid SCHEMBL7331038 | 0.82 | ALDH1A1 (0.61) | HRH3SIGMAR1ALDH1A1MCHR1SMN1; SMN2 | |
| SCHEMBL7332439 | 0.81 | SCN5A (0.51) | HRH3SIGMAR1HTTSCN5AACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9016221-B2 | Surface topographies for non-toxic bioadhesion control | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2015-04-28 | — | — | US | claimed |
| EP-1677787-B1 | COMBINATIONS OF POTASSIUM CHANNEL OPENERS AND SODIUM CHANNEL INHIBITORS OR ACTIVE SUBSTANCES INFLUENCING SODIUM CHANNELS IN ORDER TO TREAT PAINFUL CONDITIONS | MEDA PHARMA GMBH & CO KG (DE) | 2012-12-12 | — | — | EP | claimed |
| US-20100323987-A1 | COMBINATIONS OF RETIGABINE AND SODIUM CHANNEL INHIBITORS OR SODIUM CHANNEL-INFLUENCING ACTIVE COMPOUNDS FOR TREATING PAINS | VALEANT PHARMACEUTICALS NORTH AMERICA (US) | 2010-12-23 | — | — | US | claimed |
| US-7799832-B2 | Combinations of retigabine and sodium channel inhibitors or sodium channel-influencing active compounds for treating pains | VALEANT PHARMACEUTICALS NORTH AMERICA (US) | 2010-09-21 | — | — | US | claimed |
| US-20100226943-A1 | SURFACE TOPOGRAPHIES FOR NON-TOXIC BIOADHESION CONTROL | UNIVERSITY OF FLORIDA (US) | 2010-09-09 | — | — | US | claimed |
| CN-1871000-B | Combinations of potassium channel openers and sodium channel inhibitors or sodium channel-influencing active compounds for treating pain | VALEANT PHARMACEUTICALS NORTH | 2010-06-09 | — | — | CN | claimed |
| US-20090176814-A1 | COMBINATIONS OF POTASSIUM CHANNEL OPENERS AND SODIUM CHANNEL INHIBITORS OR SODIUM CHANNEL-INFLUENCING ACTIVE COMPOUNDS FOR TREATING PAINS | VALEANT PHARMACEUTICALS NORTH AMERICA (US) | 2009-07-09 | — | — | US | claimed |
| CN-101330905-A | Freeze-drying process and products obtained thereby | SCIDOSE LLC (US) | 2008-12-24 | — | — | CN | claimed |
| EP-1954244-A1 | LYOPHILIZATION PROCESS AND PRODUCTS OBTAINED THEREBY | Scidose, Llc (US) | 2008-08-13 | — | — | EP | claimed |
| WO-2007061529-A1 | LYOPHILIZATION PROCESS AND PRODUCTS OBTAINED THEREBY | SCIDOSE LLC. (US) | 2007-05-31 | — | — | WO | claimed |
| US-20070116729-A1 | Lyophilization process and products obtained thereby | SCIDOSE LLC | 2007-05-24 | — | — | US | claimed |
| CN-1871000-A | Combinations of potassium channel openers and sodium channel inhibitors or sodium channel-influencing active compounds for treating pain | VALEANT PHARMACEUTICALS NORTH (DE) | 2006-11-29 | — | — | CN | claimed |
| EP-1682137-A1 | COMBINATIONS OF POTASSIUM CHANNEL OPENERS AND SODIUM CHANNEL INHIBITORS OR SODIUM CHANNEL-INFLUENCING ACTIVE COMPOUNDS FOR TREATING PAIN | Valeant Pharmaceuticals North America (US) | 2006-07-26 | — | — | EP | claimed |
| WO-2005039577-A1 | COMBINATIONS OF POTASSIUM CHANNEL OPENERS AND SODIUM CHANNEL INHIBITORS OR SODIUM CHANNEL-INFLUENCING ACTIVE COMPOUNDS FOR TREATING PAIN | VALEANT PHARMACEUTICALS NORTH AMERICA (US) | 2005-05-06 | — | — | WO | claimed |
| US-20050090547-A1 | Combinations of retigabine and sodium channel inhibitors or sodium channel-influencing active compounds for treating pains | LABORATOIRE CHAUVIN S.A.S. (FR) | 2005-04-28 | — | — | US | claimed |
| US-20050089559-A1 | Combinations of potassium channel openers and sodium channel inhibitors or sodium channel-influencing active compounds for treating pains | VALEANT PHARMACEUTICALS NORTH AMERICA | 2005-04-28 | — | — | US | claimed |
| EP-0468825-B1 | Organosilane derivatives, pharmaceutical compositions containing them and process for preparing same | RICHTER GEDEON VEGYESZET (HU) | 1997-01-08 | — | — | EP | claimed |
| US-5340823-A | Administering a muscle relaxants for treating parkinson*s disease | RICHTER GEDEON VEGYESZETI GYAR RT. (HU) | 1994-08-23 | — | — | US | claimed |
| US-5198446-A | Muscle Relaxants | RICHTER GEDEON VEGYESZETI GYAR RT. (HU) | 1993-03-30 | — | — | US | claimed |
| EP-0468825-A1 | Organosilane derivatives, pharmaceutical compositions containing them and process for preparing same | Richter Gedeon Vegyészeti Gyár R.T. (HU) | 1992-01-29 | — | — | EP | claimed |